Kevin Ess
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 22 | 2025 | 55 | 4.880 |
Why?
| | Tumor Suppressor Proteins | 13 | 2023 | 327 | 3.240 |
Why?
| | Induced Pluripotent Stem Cells | 14 | 2025 | 251 | 1.640 |
Why?
| | TOR Serine-Threonine Kinases | 10 | 2023 | 412 | 1.500 |
Why?
| | Sirolimus | 7 | 2024 | 275 | 1.060 |
Why?
| | Astrocytoma | 3 | 2021 | 128 | 1.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 3 | 2025 | 49 | 1.030 |
Why?
| | Neural Stem Cells | 7 | 2019 | 155 | 0.980 |
Why?
| | Tumor Suppressor Protein p53 | 5 | 2017 | 530 | 0.970 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 9 | 2025 | 125 | 0.930 |
Why?
| | Multiprotein Complexes | 4 | 2013 | 163 | 0.910 |
Why?
| | Neurons | 8 | 2020 | 1588 | 0.880 |
Why?
| | Hemiplegia | 3 | 2025 | 21 | 0.880 |
Why?
| | Brain | 9 | 2024 | 2675 | 0.880 |
Why?
| | Epilepsy | 5 | 2021 | 332 | 0.830 |
Why?
| | Signal Transduction | 14 | 2023 | 5078 | 0.810 |
Why?
| | Zebrafish | 6 | 2023 | 495 | 0.760 |
Why?
| | Cell Differentiation | 10 | 2025 | 1987 | 0.740 |
Why?
| | Epilepsy, Generalized | 1 | 2021 | 19 | 0.720 |
Why?
| | Mosaicism | 1 | 2021 | 73 | 0.690 |
Why?
| | White Matter | 4 | 2017 | 145 | 0.670 |
Why?
| | Loss of Heterozygosity | 1 | 2017 | 51 | 0.560 |
Why?
| | Neurogenesis | 3 | 2017 | 147 | 0.530 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.530 |
Why?
| | Autistic Disorder | 1 | 2019 | 204 | 0.520 |
Why?
| | Heterozygote | 2 | 2017 | 292 | 0.510 |
Why?
| | Brain Neoplasms | 2 | 2021 | 1242 | 0.500 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 396 | 0.490 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 79 | 0.480 |
Why?
| | Everolimus | 4 | 2025 | 91 | 0.450 |
Why?
| | Gene Deletion | 2 | 2013 | 392 | 0.440 |
Why?
| | Mutation | 9 | 2025 | 3956 | 0.430 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2013 | 2 | 0.420 |
Why?
| | Electron-Transferring Flavoproteins | 1 | 2013 | 4 | 0.420 |
Why?
| | Zebrafish Proteins | 2 | 2013 | 287 | 0.410 |
Why?
| | Gene Knock-In Techniques | 1 | 2013 | 56 | 0.400 |
Why?
| | Carrier Proteins | 4 | 2015 | 769 | 0.400 |
Why?
| | Mice, Knockout | 12 | 2019 | 3009 | 0.400 |
Why?
| | Regenerative Medicine | 1 | 2013 | 47 | 0.400 |
Why?
| | Astrocytes | 5 | 2024 | 210 | 0.400 |
Why?
| | Kidney Tubules, Distal | 1 | 2012 | 5 | 0.390 |
Why?
| | Mitochondrial Diseases | 1 | 2013 | 91 | 0.390 |
Why?
| | Neuroglia | 2 | 2011 | 173 | 0.380 |
Why?
| | Disease Models, Animal | 13 | 2017 | 4284 | 0.380 |
Why?
| | Gene Silencing | 1 | 2013 | 195 | 0.380 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2012 | 47 | 0.380 |
Why?
| | Animals | 35 | 2025 | 36862 | 0.370 |
Why?
| | Seizures | 4 | 2021 | 430 | 0.370 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 4 | 2017 | 28 | 0.370 |
Why?
| | Immunosuppressive Agents | 2 | 2019 | 890 | 0.370 |
Why?
| | Stem Cell Transplantation | 1 | 2013 | 177 | 0.370 |
Why?
| | Corpus Callosum | 1 | 2012 | 70 | 0.370 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2015 | 455 | 0.350 |
Why?
| | Mice | 24 | 2025 | 17774 | 0.350 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 327 | 0.350 |
Why?
| | Blood-Brain Barrier | 2 | 2024 | 140 | 0.340 |
Why?
| | Myelin Sheath | 3 | 2017 | 166 | 0.340 |
Why?
| | Cilia | 1 | 2012 | 177 | 0.340 |
Why?
| | Interneurons | 1 | 2011 | 122 | 0.340 |
Why?
| | Codon, Nonsense | 1 | 2010 | 44 | 0.340 |
Why?
| | Nervous System Diseases | 1 | 2013 | 265 | 0.330 |
Why?
| | Trans-Activators | 4 | 2012 | 398 | 0.310 |
Why?
| | Cerebral Cortex | 4 | 2020 | 434 | 0.310 |
Why?
| | Humans | 47 | 2025 | 137294 | 0.300 |
Why?
| | Mutant Proteins | 2 | 2023 | 101 | 0.290 |
Why?
| | Alleles | 3 | 2017 | 892 | 0.270 |
Why?
| | Neurobiology | 1 | 2006 | 15 | 0.250 |
Why?
| | Carcinogenesis | 2 | 2019 | 217 | 0.240 |
Why?
| | Child | 12 | 2025 | 21999 | 0.240 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 3 | 2017 | 62 | 0.230 |
Why?
| | Electroencephalography | 2 | 2021 | 433 | 0.230 |
Why?
| | Huntington Disease | 2 | 2016 | 57 | 0.230 |
Why?
| | Proto-Oncogene Proteins | 3 | 1999 | 647 | 0.220 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 363 | 0.220 |
Why?
| | Cells, Cultured | 7 | 2020 | 4197 | 0.210 |
Why?
| | Proteins | 4 | 2015 | 1012 | 0.210 |
Why?
| | Transcription Factors | 4 | 2012 | 1720 | 0.200 |
Why?
| | Arrhythmias, Cardiac | 1 | 2025 | 333 | 0.190 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2014 | 176 | 0.190 |
Why?
| | Fatty Acids | 1 | 2025 | 444 | 0.190 |
Why?
| | Embryonic and Fetal Development | 2 | 1999 | 97 | 0.180 |
Why?
| | Oncogenes | 2 | 1999 | 116 | 0.180 |
Why?
| | Thymus Gland | 3 | 1999 | 313 | 0.170 |
Why?
| | Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 3 | 0.170 |
Why?
| | Mitochondria | 4 | 2015 | 947 | 0.170 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1774 | 0.170 |
Why?
| | GTPase-Activating Proteins | 1 | 2020 | 82 | 0.160 |
Why?
| | Endothelial Cells | 3 | 2025 | 779 | 0.160 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 17 | 0.160 |
Why?
| | DNA Methylation | 1 | 2025 | 644 | 0.160 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2023 | 383 | 0.160 |
Why?
| | Immunization | 1 | 2021 | 411 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 858 | 0.150 |
Why?
| | Lateral Ventricles | 1 | 2019 | 35 | 0.150 |
Why?
| | Female | 16 | 2025 | 73052 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2020 | 102 | 0.150 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 76 | 0.150 |
Why?
| | Aquaporin 4 | 1 | 2019 | 94 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 338 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1059 | 0.140 |
Why?
| | Wnt Signaling Pathway | 2 | 2023 | 192 | 0.140 |
Why?
| | Male | 14 | 2025 | 67560 | 0.140 |
Why?
| | Parkinson Disease | 2 | 2014 | 491 | 0.140 |
Why?
| | Manganese | 2 | 2014 | 63 | 0.140 |
Why?
| | Genes, p53 | 1 | 2017 | 72 | 0.140 |
Why?
| | Membrane Potentials | 1 | 2018 | 283 | 0.140 |
Why?
| | Fibrosis | 1 | 2019 | 552 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1577 | 0.130 |
Why?
| | Demyelinating Diseases | 1 | 2016 | 85 | 0.130 |
Why?
| | Phenotype | 3 | 2020 | 3202 | 0.130 |
Why?
| | Child, Preschool | 7 | 2025 | 11080 | 0.120 |
Why?
| | Myocytes, Cardiac | 2 | 2023 | 528 | 0.120 |
Why?
| | Central Nervous System | 1 | 2017 | 258 | 0.120 |
Why?
| | Genomic Instability | 1 | 2016 | 53 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 622 | 0.120 |
Why?
| | Infant | 6 | 2018 | 9451 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 327 | 0.120 |
Why?
| | Polyesters | 1 | 2015 | 78 | 0.110 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 66 | 0.110 |
Why?
| | Cell Line | 6 | 2015 | 2841 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 263 | 0.110 |
Why?
| | Flow Cytometry | 2 | 2024 | 1184 | 0.110 |
Why?
| | Cadmium | 1 | 2014 | 69 | 0.110 |
Why?
| | Chromatin | 2 | 2015 | 519 | 0.110 |
Why?
| | Enhancer Elements, Genetic | 1 | 1995 | 190 | 0.110 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 867 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 1995 | 176 | 0.110 |
Why?
| | Copper | 1 | 2014 | 108 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3568 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2015 | 139 | 0.110 |
Why?
| | RNA, Messenger | 3 | 2020 | 2839 | 0.110 |
Why?
| | Checklist | 1 | 2014 | 93 | 0.110 |
Why?
| | Glutamic Acid | 2 | 2007 | 248 | 0.100 |
Why?
| | Brain Diseases | 1 | 2014 | 141 | 0.100 |
Why?
| | Founder Effect | 1 | 2013 | 11 | 0.100 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 81 | 0.100 |
Why?
| | Neoplasm Invasiveness | 1 | 1995 | 508 | 0.100 |
Why?
| | Corpus Striatum | 1 | 2014 | 167 | 0.100 |
Why?
| | Abdominal Neoplasms | 1 | 2013 | 39 | 0.100 |
Why?
| | Manganese Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2016 | 575 | 0.100 |
Why?
| | Parkinson Disease, Secondary | 1 | 2012 | 7 | 0.100 |
Why?
| | Stem Cells | 3 | 2023 | 593 | 0.100 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 52 | 0.100 |
Why?
| | Homozygote | 1 | 2013 | 203 | 0.100 |
Why?
| | Fibroblasts | 1 | 2017 | 993 | 0.100 |
Why?
| | Adolescent | 7 | 2025 | 21499 | 0.100 |
Why?
| | Paired Box Transcription Factors | 1 | 2012 | 46 | 0.090 |
Why?
| | Genetic Testing | 1 | 2015 | 454 | 0.090 |
Why?
| | Chlorides | 1 | 2012 | 136 | 0.090 |
Why?
| | Exons | 1 | 2013 | 351 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 279 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 388 | 0.090 |
Why?
| | Blotting, Western | 2 | 2012 | 1226 | 0.090 |
Why?
| | Eye Proteins | 1 | 2012 | 92 | 0.090 |
Why?
| | SOXB1 Transcription Factors | 1 | 2012 | 61 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 186 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 187 | 0.090 |
Why?
| | Glioblastoma | 1 | 1995 | 343 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2164 | 0.090 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2012 | 135 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1169 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 301 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 194 | 0.090 |
Why?
| | Quinolines | 1 | 2012 | 177 | 0.090 |
Why?
| | Cell Lineage | 2 | 2019 | 348 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 436 | 0.090 |
Why?
| | Cell Size | 1 | 2010 | 91 | 0.090 |
Why?
| | Lung | 1 | 2023 | 4067 | 0.080 |
Why?
| | Environmental Pollutants | 1 | 2012 | 159 | 0.080 |
Why?
| | Autophagy | 1 | 2013 | 281 | 0.080 |
Why?
| | Liver | 3 | 2015 | 1941 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 544 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 413 | 0.080 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 167 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 640 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 844 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2479 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 198 | 0.080 |
Why?
| | Genetic Markers | 2 | 2005 | 344 | 0.080 |
Why?
| | Cell Death | 1 | 2011 | 372 | 0.080 |
Why?
| | Biomedical Research | 1 | 2016 | 693 | 0.080 |
Why?
| | Hepatocytes | 1 | 2010 | 220 | 0.080 |
Why?
| | Spinal Cord Injuries | 1 | 2013 | 212 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-myb | 3 | 1999 | 10 | 0.080 |
Why?
| | Behavior, Animal | 1 | 2012 | 497 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2608 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 613 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1061 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 427 | 0.070 |
Why?
| | Pyrazoles | 1 | 2012 | 423 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 406 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 506 | 0.070 |
Why?
| | Aging | 2 | 2023 | 1864 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2007 | 100 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1734 | 0.070 |
Why?
| | Adult | 7 | 2021 | 37724 | 0.070 |
Why?
| | Protein Biosynthesis | 2 | 2013 | 434 | 0.070 |
Why?
| | DNA | 2 | 2012 | 1459 | 0.060 |
Why?
| | Sleep | 1 | 2012 | 755 | 0.060 |
Why?
| | Mental Disorders | 1 | 2014 | 1077 | 0.060 |
Why?
| | Karyotyping | 2 | 2016 | 105 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Anxiety | 1 | 2012 | 1036 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2010 | 1045 | 0.060 |
Why?
| | Synaptic Transmission | 1 | 2007 | 289 | 0.060 |
Why?
| | Neuronal Plasticity | 1 | 2007 | 290 | 0.060 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 226 | 0.060 |
Why?
| | Death, Sudden, Cardiac | 1 | 2025 | 185 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2014 | 71 | 0.050 |
Why?
| | Mice, Nude | 2 | 2015 | 696 | 0.050 |
Why?
| | Centrosome | 1 | 2023 | 71 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1904 | 0.050 |
Why?
| | DNA Damage | 2 | 2016 | 422 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 658 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2025 | 3546 | 0.050 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2002 | 26 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2904 | 0.050 |
Why?
| | Binding Sites | 2 | 2015 | 1309 | 0.050 |
Why?
| | Electrocardiography | 1 | 2025 | 630 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2419 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 596 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 126 | 0.040 |
Why?
| | Drug Approval | 1 | 2021 | 87 | 0.040 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 77 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 674 | 0.040 |
Why?
| | Malformations of Cortical Development | 1 | 2020 | 13 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2020 | 56 | 0.040 |
Why?
| | Seizures, Febrile | 1 | 2019 | 21 | 0.040 |
Why?
| | Genetic Variation | 1 | 2025 | 988 | 0.040 |
Why?
| | Advisory Committees | 1 | 2021 | 219 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 75 | 0.040 |
Why?
| | Stroke Volume | 1 | 2023 | 619 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 29 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2023 | 540 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1119 | 0.040 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Odontogenesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Digestive System | 1 | 1999 | 28 | 0.040 |
Why?
| | Machine Learning | 1 | 2024 | 491 | 0.040 |
Why?
| | Culture Media | 1 | 2019 | 167 | 0.040 |
Why?
| | Hair Follicle | 1 | 1999 | 46 | 0.040 |
Why?
| | Adenosine Deaminase | 2 | 1996 | 36 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 127 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 202 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1773 | 0.040 |
Why?
| | Thyroid Gland | 1 | 1999 | 94 | 0.040 |
Why?
| | In Situ Hybridization | 1 | 1999 | 316 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2019 | 126 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2018 | 45 | 0.040 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2017 | 20 | 0.030 |
Why?
| | Mitosis | 1 | 1999 | 193 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2018 | 239 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3414 | 0.030 |
Why?
| | Trachea | 1 | 1999 | 237 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 345 | 0.030 |
Why?
| | Strategic Planning | 1 | 2016 | 3 | 0.030 |
Why?
| | Zinostatin | 1 | 2016 | 1 | 0.030 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2016 | 16 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 2015 | 10 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2015 | 26 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 119 | 0.030 |
Why?
| | Fluorescence Polarization | 1 | 2015 | 37 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 49 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 1995 | 66 | 0.030 |
Why?
| | Two-Hybrid System Techniques | 1 | 2015 | 59 | 0.030 |
Why?
| | Anisotropy | 1 | 2015 | 79 | 0.030 |
Why?
| | Base Sequence | 2 | 1996 | 2182 | 0.030 |
Why?
| | Methylmercury Compounds | 1 | 2014 | 8 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2015 | 144 | 0.030 |
Why?
| | Troponin I | 1 | 2015 | 84 | 0.030 |
Why?
| | Point Mutation | 1 | 1995 | 235 | 0.030 |
Why?
| | Goals | 1 | 2016 | 169 | 0.030 |
Why?
| | Introns | 1 | 1995 | 256 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1923 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 387 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 340 | 0.030 |
Why?
| | Axons | 1 | 2015 | 199 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 403 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.030 |
Why?
| | Genes, Lethal | 1 | 2013 | 30 | 0.030 |
Why?
| | HeLa Cells | 1 | 1995 | 637 | 0.030 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2013 | 26 | 0.030 |
Why?
| | Manganese Compounds | 1 | 2012 | 2 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2014 | 216 | 0.030 |
Why?
| | United States | 3 | 2021 | 14742 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 452 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2012 | 113 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 731 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2836 | 0.020 |
Why?
| | PAX6 Transcription Factor | 1 | 2012 | 21 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 808 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1946 | 0.020 |
Why?
| | Homeostasis | 2 | 2007 | 619 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2014 | 323 | 0.020 |
Why?
| | Age Factors | 1 | 1999 | 3297 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2012 | 126 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 1995 | 558 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2147 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2012 | 169 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 13163 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6743 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1759 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 33310 | 0.020 |
Why?
| | Models, Molecular | 1 | 2015 | 1594 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 622 | 0.020 |
Why?
| | Risk Factors | 2 | 2014 | 10368 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1700 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 2225 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5753 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2052 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6054 | 0.020 |
Why?
| | Nerve Degeneration | 1 | 2007 | 46 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3283 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2007 | 100 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 156 | 0.020 |
Why?
| | Neocortex | 1 | 2007 | 38 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1995 | 1998 | 0.020 |
Why?
| | Long-Term Potentiation | 1 | 2007 | 198 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2003 | 77 | 0.010 |
Why?
| | Gliosis | 1 | 2003 | 28 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 10800 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 217 | 0.010 |
Why?
| | Hippocampus | 1 | 2007 | 895 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 219 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6818 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 15639 | 0.010 |
Why?
| | Synapses | 1 | 2003 | 427 | 0.010 |
Why?
| | Aged | 1 | 2016 | 23851 | 0.010 |
Why?
| | Awards and Prizes | 1 | 1996 | 67 | 0.010 |
Why?
| | Hematopoiesis | 1 | 1996 | 190 | 0.010 |
Why?
| | Societies, Medical | 1 | 1996 | 822 | 0.010 |
Why?
| | Biomarkers | 1 | 2002 | 4164 | 0.010 |
Why?
|
|
Ess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|